Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Consun Pharmaceutical
Watchlist
Long Term, Pure Play in Chinese Ageing Population with Pristine Balance Sheet!
Equity Bottom-Up
365 Views
11 Nov 2016 04:06
Substitute product. In the aging population in China where older people (70 years and older) are more prone to Chronic Kidney Disease (CKD) and...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »
Loading
Trending Collections
More »
South Korea
Event-Driven
Japan
Equity Bottom-Up
Equity Derivatives
India
Philippines
China
Index Rebalance
Asia Event-Driven
Trending Insights
More »
Toyota Industries (6201 JP): Thoughts on Intrinsic Value
Foshan Haitian Flavouring & Food (3288 HK): Offering Details & Index Inclusion
Virgin Australia (VGN AU): Touch & Go for Index Inclusion
Kioxia IPO Lockup Expiry - US$6.7bn Release, with Shareholders Eager to Sell
MINISO (9896 HK)'s (Possible) TOP TOY Spin-Off Is Priced In
Top Unpaywalled Insights
More »
Bearishness Persist in Soybeans Despite Rebound Hopes
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
[IO Technicals 2025/23] Bearish Momentum Persists
VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Consun Pharma 2016 FY: What's in the New Concoction?
05 May 2017
Consun Pharma - FY16 Announced; Strong Growth and Increased Stake in Yulin
30 Mar 2017
Consun Pharmaceutical Group: Company Buys Back 146.1m Shares from Hony Capital
07 Feb 2017
Long Term, Pure Play in Chinese Ageing Population with Pristine Balance Sheet!
11 Nov 2016
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x